Changeflow GovPing Healthcare & Life Sciences Spectral and Ultra High Resolution CT Systems f...
Routine Notice Added Final

Spectral and Ultra High Resolution CT Systems for Non-Invasive Detection of Myocardial Ischemia: Stress CT Perfusion VS. FFR-CT

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

ClinicalTrials.gov registered observational study NCT07544277 on April 22, 2026, evaluating Photon Counting Detector (PCD)-CT technology combined with Fractional Flow Reserve derived from CT (FFR-CT) and spectral CT perfusion (CTP) for non-invasive detection of significant coronary artery disease (CAD). The study aims to address limitations of energy-integrating detector CT, where FFR-CT shows suboptimal performance and CTP involves high radiation exposure. Conditions under study include FFR-CT, CT angiography, CT perfusion, and coronary arterial disease.

“Both these approaches may benefit by the introduction of the new Photon Counting Detector (PCD)-CT technology, but data completely lacks.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 667 changes logged to date.

What changed

ClinicalTrials.gov registered a new observational study (NCT07544277) titled "Spectral and Ultra High Resolution CT Systems for Non-Invasive Detection of Myocardial Ischemia: Stress CT Perfusion VS. FFR-CT." The study focuses on evaluating Photon Counting Detector (PCD)-CT technology, which may overcome limitations of conventional energy-integrating detector CT in assessing coronary artery disease hemodynamics. The study covers conditions including FFR-CT, CT angiography, CT perfusion, and coronary arterial disease, with no stated compliance deadline or penalty information.

Healthcare providers and clinical investigators involved in cardiac imaging research may benefit from awareness of this trial's methodology, as its findings could inform future non-invasive assessment approaches for myocardial ischemia. Medical device manufacturers producing advanced CT systems, particularly photon-counting detector technology, may find this trial relevant to product development and evidence-generation pathways.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Spectral and Ultra High Resolution CT Systems for Non-Invasive Detection of Myocardial Ischemia: Stress CT Perfusion VS. FFR-CT

Observational NCT07544277 Kind: OBSERVATIONAL Apr 22, 2026

Abstract

Coronary artery disease (CAD) is the leading cause of mortality and morbidity worldwide. Coronary Computed Tomography angiography (CCTA) gained a pivotal clinical role for excellent sensitivity in rule-out CAD, but has limited specificity for a tendency to overestimate stenoses and for the lack of information about their hemodynamic impact. Fractional Flow Reserve derived from CT (FFR-CT) and stress CT perfusion (CTP) have been recently proposed to complement CCTA in the non-invasive assessment of myocardial ischemia, increasing the specificity and avoiding unnecessary catheterization. However, on energy-integrating (EID)-CT, FFR-CT has suboptimal performance, while CTP is affected by high radiation exposure. Both these approaches may benefit by the introduction of the new Photon Counting Detector (PCD)-CT technology, but data completely lacks. Aim of the study is to assess the performance of PCD-CT in the identification of significant CAD combining CCTA with FFR-CT and spectral CTP.

Conditions: FFR-CT, CT Angiography, CT Perfusion, Coronary Arterial Disease (CAD)

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07544277

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Clinical trial registration Medical imaging research
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!